Brief Article
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 7, 2013; 19(45): 8357-8365
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8357
Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients
Sith Phongkitkarun, Kuruwin Limsamutpetch, Penampai Tannaphai, Janjira Jatchavala
Sith Phongkitkarun, Kuruwin Limsamutpetch, Penampai Tannaphai, Janjira Jatchavala, Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Ratchatewi, Bangkok 10400, Thailand
Author contributions: Phongkitkarun S and Limsamutpetch K contributed to the study design, statistical analyses and wrote the first draft; Phongkitkarun S, Limsamutpetch K and Tannaphai P contributed to the data acquisition; Phongkitkarun S and Jatchavala J revised the manuscript.
Correspondence to: Sith Phongkitkarun, MD, Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchatewi, Bangkok 10400, Thailand. sith.bkk@gmail.com
Telephone: +66-81-7542780 Fax: +66-2-2011274
Received: May 21, 2013
Revised: August 6, 2013
Accepted: September 16, 2013
Published online: December 7, 2013
Abstract

AIM: To determine the added value of hepatobiliary phase (HBP) gadoxetic acid-enhanced magnetic resonance imaging (MRI) in evaluating hepatic nodules in high-risk patients.

METHODS: The institutional review board approved this retrospective study and waived the requirement for informed consent. This study included 100 patients at high risk for hepatocellular carcinoma (HCC) and 105 hepatic nodules that were larger than 1 cm. A blind review of two MR image sets was performed in a random order: set 1, unenhanced (T1- and T2-weighted) and dynamic images; and set 2, unenhanced, dynamic 20-min and HBP images. The diagnostic accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were compared for the two image sets. Univariate and multivariate analyses were performed on the MR characteristics utilized to diagnose HCC.

RESULTS: A total of 105 hepatic nodules were identified in 100 patients. Fifty-nine nodules were confirmed to be HCC. The diameter of the 59 HCCs ranged from 1 to 12 cm (mean: 1.9 cm). The remaining 46 nodules were benign (28 were of hepatocyte origin, nine were hepatic cysts, seven were hemangiomas, one was chronic inflammation, and one was focal fat infiltration). The diagnostic accuracy significantly increased with the addition of HBP images, from 88.7% in set 1 to 95.5% in set 2 (P = 0.002). In set 1 vs set 2, the sensitivity and NPV increased from 79.7% to 93.2% and from 78.9% to 91.8%, respectively, whereas the specificity and PPV were not significantly different. The hypointensity on the HBP images was the most sensitive (93.2%), and typical arterial enhancement followed by washout was the most specific (97.8%). The multivariate analysis revealed that typical arterial enhancement followed by washout, hyperintensity on T2-weighted images, and hypointensity on HBP images were statistically significant MRI findings that could diagnose HCC (P < 0.05).

CONCLUSION: The addition of HBP gadoxetic acid-enhanced MRI statistically improved the diagnostic accuracy in HCCs larger than 1 cm. Typical arterial enhancement followed by washout and hypointensity on HBP images are useful for diagnosing HCC.

Keywords: Magnetic resonance imaging, Liver, Gadoxetic acid, Hepatobiliary phase, Hepatocellular carcinoma

Core tip: This study demonstrated the added value of hepatobiliary phase gadoxetic acid-enhanced magnetic resonance imaging (MRI) for diagnosing hepatocellular carcinoma, based on the changes in contrast uptake on hepatobiliary phase images during hepatocarcinogenesis. The pitfalls of interpreting hepatobiliary phase MRI are important to recognize in obtaining the most accurate results.